Towards the elucidation of the true impact of adipocytokines on cardiovascular risk in rheumatoid arthritis

被引：0
|
作者：
Patrick H Dessein
Ahmed Solomon
机构：
[1] University of the Witwatersrand,Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences
[2] University of the Witwatersrand,Department of Rheumatology, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences
来源：
Arthritis Research & Therapy | / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Adipo(cyto)kines are mostly produced by adipose tissue and orchestrate the adverse impact of excess adiposity on cardiovascular risk. Adipokines also contribute importantly to the pathophysiology of rheumatoid arthritis. Congruent with data reported in previous investigations, Kang and colleagues report in this issue of Arthritis Research & Therapy that adipokine concentrations are further associated with metabolic risk and inflammation and that the leptin–adiponectin ratio associates with the carotid artery resistive index in rheumatoid arthritis. Guided by evidence reported thus far on cardiovascular risk, we discuss six reasons why careful elucidation of adipokine–cardiovascular risk relations is needed in rheumatoid arthritis.
引用
收藏
相关论文
共 50 条
  • [1] Towards the elucidation of the true impact of adipocytokines on cardiovascular risk in rheumatoid arthritis
    Dessein, Patrick H.
    Solomon, Ahmed
    [J]. ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [2] Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management
    Dessein, Patrick H.
    Semb, Anne G.
    Gonzalez-Gay, Miguel A.
    Popa, Calin D.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [3] Modifiable Rheumatoid Arthritis Factors and Impact on Cardiovascular Risk
    Liao, Katherine
    Etzel, Carol J.
    Greenberg, Jeffrey D.
    Guan, Hongshu
    Kremer, Joel
    Solomon, Daniel H.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] Adipocytokines in rheumatoid arthritis and obesity
    Fagerer N.
    Kullich W.
    [J]. Wiener Medizinische Wochenschrift, 2010, 160 (15-16) : 391 - 398
  • [5] Cardiovascular risk in rheumatoid arthritis
    Nurmohamed, Michael T.
    [J]. AUTOIMMUNITY REVIEWS, 2009, 8 (08) : 663 - 667
  • [6] Cardiovascular risk in rheumatoid arthritis
    Soubrier, Martin
    Chamoux, Nicolas Barber
    Tatar, Zuzana
    Couderc, Marion
    Dubost, Jean-Jacques
    Mathieu, Sylvain
    [J]. JOINT BONE SPINE, 2014, 81 (04) : 298 - 302
  • [7] Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
    Aronov, Avi
    Kim, Yoo Jin
    Sweiss, Nadera J.
    Nazir, Noreen T.
    [J]. AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 12
  • [8] IMPACT OF ADJUSTING CARDIOVASCULAR RISK SCORES TO KNOWN RISK RATIOS IN RHEUMATOID ARTHRITIS
    Bailey, Kimberley A.
    Kumar, Namita
    [J]. RHEUMATOLOGY, 2009, 48 : I130 - I130
  • [9] STATE OF ADIPOCYTOKINES IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Krivotulova, I.
    Chernysheva, T.
    Korochina, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1256 - 1256
  • [10] Elevations in adipocytokines and mortality in rheumatoid arthritis
    Baker, Joshua F.
    England, Bryant R.
    George, Michael D.
    Wysham, Katherine
    Johnson, Tate
    Kunkel, Gary
    Sauer, Brian
    Hamilton, Bartlett C.
    Hunter, Carlos D.
    Duryee, Michael J.
    Monach, Paul
    Kerr, Gail
    Reimold, Andreas
    Xiao, Rui
    Thiele, Geoff M.
    MIkuls, Ted R.
    [J]. RHEUMATOLOGY, 2022, 61 (12) : 4924 - 4934
12345